BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Very collaborative, willing to try new things.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Lots of collaboration and there are events to participate in each month
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Feel that they are leading the company in the right direction. Enjoy the transparency.
Quelle est la meilleure partie de votre programme de rémunération?
The pay seems fair, and the bonus structure seems to be average with the industry.
Qu’est-ce qui vous rend le plus heureux au travail?
really enjoy the work that I am doing and able to do push the envelope on some things.
Other Employee Reviews for BlueRock Therapeutics
×